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Oxidative stress plays an important role in the pathophysiology of vascular diseases. Reactive
oxygen species, especially superoxide anion and hydrogen peroxide, are important signalling
molecules in cardiovascular cells. Enhanced superoxide production increases nitric oxide
inactivation and leads to an accumulation of peroxynitrites and hydrogen peroxide. Reactive
oxygen species participate in growth, apoptosis and migration of vascular smooth muscle cells,
in the modulation of endothelial function, including endothelium-dependent relaxation and
expression of proinflammatory phenotype, and in the modification of the extracellular matrix.
All these events play important roles in vascular diseases such as hypertension, suggesting that
the sources of reactive oxygen species and the signalling pathways that they modify may represent
important therapeutic targets. Potential sources of vascular superoxide production include
NADPH-dependent oxidases, xanthine oxidases, lipoxygenases, mitochondrial oxidases and
nitric oxide synthases. Studies performed during the last decade have shown that NADPH oxidase
is the most important source of superoxide anion in phagocytic and vascular cells. Evidence from
experimental animal and human studies suggests a significant role of NADPH oxidase activation
in the vascular remodelling and endothelial dysfunction found in cardiovascular diseases.
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Oxidative stress is defined as the imbalanced redox
state in which pro-oxidants overwhelm antioxidant
capacity, resulting in increased production of reactive
oxygen species (ROS). ROS have been implicated in the
pathogenesis of virtually every stage of vascular lesion
formation in atherosclerosis (Madamanchi et al. 2005;
Mueller et al. 2005). Increasing evidence supports a role
for oxidative stress in the pathogenesis of experimental
and essential hypertension (Touyz, 2004). It has been
extensively described that ROS contribute to blood
pressure elevation by influencing vascular function and
structure (Zalba et al. 2001b; Dro¨ge, 2002).
Production and metabolism of reactive oxygen
species
Traditionally, macrophages have been assumed to be the
source of the most of the ROS in the vessel wall, and there
is no doubt that these cells play an important role in vessel
pathology (Cathcart, 2004). However, it has become clear
that virtually all cells in the vessel wall (endothelial, smooth
muscle and adventitial cells) produce ROS, in varying
amounts and in response to diverse stimuli, which can
then act in an autocrine or paracrine fashion to modulate
cellular function (Griendling et al. 2000).
ROS play a physiological role in the vessel wall
and participate as second messengers in endothelium-
dependent function, in smooth muscle cell and endothelial
cell growth and survival, and in remodelling of the
vessel wall. Each of these responses, when uncontrolled,
contributes to vascular diseases (Griendling & Harrison,
1999; Irani, 2000; Taniyama & Griendling, 2003). The
major vascular ROS is superoxide anion (·O2−), which
inactivates nitric oxide (NO), the main vascular relaxing
factor, thus impairing relaxation (Kojda & Harrison,
1999; Cai & Harrison, 2000). Dismutation of ·O2− by
superoxide dismutase (SOD) produces hydrogen peroxide
(H2O2), a more stable ROS, which, in turn, is converted
to water by catalase and glutathione peroxidase. H2O2 and
other peroxides appear to be important in the regulation
of growth-related signalling in vascular smooth muscle
cells (VSMCs) and inflammatory responses in vascular
lesions (Li et al. 1997; Irani, 2000). High levels of ·O2−,
the consequent accumulation of H2O2 and diminished
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NO bioavailability play a critical role in the modulation
of vascular remodelling. Finally, the reaction product
between ·O2− and NO, peroxynitrite, constitutes a strong
oxidant molecule, which is able to oxidize proteins,
lipids and nucleic acids, causing cell damage (Beckman
& Koppenol, 1996). These pathological processes are
associated with hypertension because they contribute to
the narrowing of the arterial lumen and consequently to
increased peripheral resistance and blood pressure (Fig. 1).
NADPH oxidase systems
Not only are there different cellular sources of ROS, but
also cells use different enzymes to produce ROS in different
circumstances. In addition to mitochondrial sources of
ROS, ·O2− can be derived from xanthine oxidase, NADPH






































Figure 1. Generation of reactive oxygen species
Many enzymatic systems have the potential to generate reactive oxygen species. This flow diagram
illustrates the functional and structural consequences of reactive oxygen species in arterial hypertension.
An enhanced superoxide production, mainly due to NADPH oxidase activation, is involved in endothelial
dysfunction and vascular remodelling by decreasing NO bioavailability and increasing production of
H2O2 and ONOO−. eNOS, endothelial nitric oxide synthase; SOD, superoxide dismutase; VSMCs, vascular
smooth muscle cells; ECs, endothelial cells.
oxidases, cyclooxygenases, lipoxygenases and uncoupled
nitric oxide synthase. On the basis of experimental and
clinical studies it has been proposed that NADPH oxidase
is the predominant ·O2−-producing enzyme in the context
of oxidative stress in cardiovascular diseases (Mueller et al.
2005).
The best-characterized NADPH oxidase is that found in
phagocytes, where this enzyme is also the major inducible
source of ·O2− and where it plays a role in immune
protection owing to its bactericidal activity (Cathcart,
2004). The phagocytic oxidase consists of a membrane-
associated cytochrome that comprises a large subunit,
gp91phox (‘phox’ being derived from phagocytic oxidase),
and a small one, p22phox. Besides these, there are at least
three cytosolic subunits (p47phox, p67phox and p40phox)
and a low-molecular-weight G protein (rac2; Cross &
Segal, 2004). All the subunits present on phagocytic
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NADPH oxidase have been identified in vascular cells,
as well as p47phox, p67phox and gp91phox (nox2)
homologues nox1, nox4 and nox5 (Lassegue & Clempus,
2003). However, several studies have confirmed that
p22phox is present in all NADPH oxidase systems and that
this subunit is essential for the functionality of the enzyme
(Ushio-Fukai et al. 1996; Lassegue & Clempus, 2003).
Upon cell stimulation, p47phox becomes phosphorylated,
and the cytosolic subunits form a complex which migrates
to the membrane where it binds to the cytochrome. Then
electrons are transferred from the substrate, NADPH, to
O2, leading to ·O2− generation (Brandes & Kreuzer, 2005).
Role of reactive oxygen species in vascular
physiology and pathophysiology
The intracellular and extracellular production of ROS
and the consequent activation of specific signalling
pathways coordinate several integrated physiological
responses in cardiovascular tissues. Numerous studies
have shown that ROS influence cellular processes in
vascular remodelling by turning on several intracellular
signalling cascades. ROS potently activate extracellular
signal regulated kinases (ERKs), mitogen-activated protein
kinases (MAPKs) members important in cell growth and
differentation; receptor and non-receptor tyrosin kinases,
which have been implicated in cardiovascular remodelling
and vascular damage; and protein tyrosin phosphatases
and transcription factors, such as NFkB and AP-1, which
induce expression of pro-inflammatory genes that play
a role in the vascular inflammation associated with
hypertension and atherosclerosis (recently reviewed by
Touyz & Schiffrin, 2004; Cai, 2005). Nevertheless, in spite
of all this evidence, the exact molecular targets of ROS have
not been clarified. The physiological processes coordinated
by ROS have been analysed in experimental animal models
as well as in human disease, showing their important
role in the development of hypertensive vascular disease,
since they favour structural and functional alterations
such as vascular remodelling, augmented deposition of
extracellular matrix proteins, inflammatory processes and
increased endothelial permeability.
Several studies have established the role of ROS in
growth processes that contribute further to vascular injury
and remodelling. Angiotensin type 1 (AT1) receptor-
mediated production of ·O2− generated by NADPH
oxidase is followed by an increased intracellular H2O2,
which may participate as a second messenger for the long-
term responses of angiotensin II, such as hypertrophy or
hyperplasia of VSMCs (Griendling et al. 1994; Ushio-
Fukai et al. 1996; Zafari et al. 1998). Angiotension II-
induced hypertrophy can be inhibited by the flavoprotein
inhibitor DPI (Griendling et al. 1994), by antisense
p22phox transfection (Ushio-Fukai et al. 1996) and
by catalase overexpression (Zafari et al. 1998), thus
supporting the role of vascular NADPH oxidase. Our
group reported an enhanced NADPH oxidase-driven
·O2− production in the aorta of the adult spontaneously
hypertensive rat (SHR), which develops vascular wall
hypertrophy (Zalba et al. 2000; Fig. 2). A recent study using
transgenic mice that overexpress the p22phox subunit in
VSMCs demonstrated that increased H2O2 is associated
with vascular hypertrophy (Weber et al. 2005). The
importance of these studies in experimental animal models
is confirmed by studies with human VSMCs showing
that enhanced NADPH oxidase-dependent oxidative
stress is associated with angiotensin II-induced vascular
remodelling in essential hypertension (Touyz & Schiffrin,
2001).
ROS also modulate vascular remodelling by increasing
deposition of extracellular matrix proteins. Collagen
degradation depends on the activity of enzymes known
as metalloproteinases (MMPs; Wainwright, 2004). These
MMPs are secreted by macrophages and VSMCs in
an inactive form (Galis & Khatri, 2002). ROS activate
MMP2 and MMP9, which promote degradation of
basement membrane and elastin, respectively, in cultured
human smooth muscle cells (Rajagopalan et al. 1996).
In particular, peroxynitrite rapidly increases MMP2
activity in the coronary effluent (Wang et al. 2002).
Furthermore, increased aldosterone-induced systemic
oxidative stress is associated with an increased collagen
and fibronectin deposition related to the development
of vascular remodelling (Pu et al. 2003). This study
demonstrates for the first time that the inflammatory
response is associated with vascular remodelling and
enhanced oxidative stress, which may be induced by
endothelin-1 in this experimental model of hypertension.
Redox-sensitive inflammatory processes also contribute
to vascular remodelling in hypertension. Expression
of intracellular adhesion molecule-1 (ICAM-1), which
participates in the inflammatory process, is increased
in the aorta from aldosterone-infused rats (Pu et al.
2003). Moreover, in an experimental model of angiotensin
II-enhanced oxidative stress, where the role of NADPH
oxidase is clearly demonstrated, induction of ICAM-
1 expression is associated with tissue hypertrophy (Liu
et al. 2003).
Finally, the endothelial cell redox rheostat is primarily
regulated by the dynamic interaction between NO and
·O2−. NO inhibits platelet aggregation and adhesion
of leucocytes to the endothelium. Increased endothelial
permeability results in the extravasation of plasma
proteins and the recruitment of inflammatory proteins
and cells. Phagocytic cells participate in oxidative stress
and inflammation in patients with hypertension (Kristal
et al. 1998). In the study by Liu et al. (2003), angiotensin
II-enhanced NADPH oxidase activity plays an important
role in vascular hypertrophy, induction of ICAM-1
expression and the consequent leucocyte infiltration.
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It is important to note that in cardiovascular diseases not
only the vascular oxidase but also the phagocytic NADPH
oxidase plays an important role in ·O2− production, since
monocytes and lymphocytes can infiltrate cardiovascular
tissues (Cathcart, 2004). The relevance of this is underlined
by findings showing an enhanced phagocytic NADPH
oxidase-dependent ·O2− production in hypertensive
patients (Fortun˜o et al. 2004).
Activation and regulation of the NADPH oxidase
systems
Several potential stimulating factors of NADPH oxidase
systems deserve to be considered in the setting of arterial
hypertension. Although vascular NADPH oxidases are
constitutive enzymes, humoral factors have been shown to
regulate their activity. It has been extensively demonstrated
that vasoactive agonists, such as angiotensin II, endo-
thelin 1(ET-1) and tumor necrosis factor-alpha (TNF-α),
regulate NADPH oxidase in vascular cells (De Keulenaer
et al. 1998; Liu et al. 2003; Pu et al. 2003). Furthermore,
our group has recently reported that phagocytic cells
from hypertensive patients show a higher response
to physiological concentrations of angiotensin II and
ET-1 than cells obtained from normotensive subjects,
supporting a potential role of these factors in the activation
of mononuclear cells in the hypertensive state (Fortun˜o
et al. 2004).
However, mechanical forces, including cyclic stretch and
laminar and oscillatory shear stress, stimulate NADPH
oxidase activity. In angiotensin II-infused rats, a reduction
























Figure 2. NADPH oxidase activity and vascular hypertrophy in rat aorta
A, NADH-driven ·O2− production in homogenates from aortic tissue from adult Wistar Kyoto (WKY30)
and spontaneously hypertensive rats (SHR30). Bars represent means ± S.E.M. of 10 animals in each group.
∗P < 0.05 compared with WKY30. B, representative cross-sections of aortas from adult WKY30 and SHR30
stained with Haematoxylin and showing tissue hypertrophy in the SHR30. This figure is adapted from
Zalba et al. (2000) with permission from Lippincott Williams & Wilkins.
of blood pressure is associated with normalized aortic ·O2−
production (Virdis et al. 2002). In fact, high intraluminal
pressure itself elicits increased ·O2− production in rat
femoral arterial branches, and this effect is mediated by
NADPH oxidase activation (Ungvari et al. 2003). The
question of whether mechanical forces may also play a
role in regulation of the phagocytic enzymatic system
merits investigation. Nevertheless, our findings that ·O2−
production is increased in those treated hypertensive
patients in whom blood pressure remains raised suggest
that mechanical forces may play an important regulatory
role in the activation of the phagocytic NADPH oxidase
(Fortun˜o et al. 2004). In this study we showed that
there were no differences in the NADPH oxidase activity
between treated, although uncontrolled, and not-treated
hypertensive patients and, thus, both groups of patients
showed elevated ·O2− levels with respect to normotensive
subjects and treated hypertensive patients whose blood
pressure levels were controled. Nevertheless, humoral
factors, which are also modulated by antihypertensive
treatment, may also play a role of in the upregulation of
NADPH oxidase activity.
Finally, genetic factors might regulate NADPH oxidase-
driven ·O2− production in hypertension. A particular
interest has been shown in the gene encoding the
p22phox subunit, which possesses a significant number
of genetic polymorphisms within the promoter and
coding sequences, some of which are able to influence
gene expression and NADPH oxidase activity (Zalba
et al. 2005). Our group reported the existence of five
polymorphisms in the promoter region of the p22phox
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gene, which are associated with higher promoter activity
in VSMCs of the SHR (Zalba et al. 2001a). More
recently, we have characterized the promoter of the
human p22phox gene, in which we have discovered
a novel variation, the −930A/G polymorphism, which
is associated with essential hypertension (Moreno et
al. 2003). The relevance of this association has been
underlined recently by a study demonstrating the
functionality of the −930A/G polymorphism associated
with diminished NO bioavailability (San Jose´ et al. 2004).
Conclusions
Increased oxidative stress, mainly due to an enhanced
NADPH oxidase activity, results in an exaggerated ·O2−
production that favours the accumulation of H2O2 and
peroxynitrites and that diminishes NO availability. These
pathological processes are associated with hypertension,
because they contribute to the narrowing of the arterial
lumen, and consequently to increased peripheral resistance
and blood pressure.
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